About NextPharma
NextPharma is a Healthcare company based in Gottingen (Germany) founded in 2000, and was acquired by CapVest in June 2017. Pharmaceutical development and manufacturing services are provided contractually. NextPharma offers products and services including Pharmaceutical Development, Clinical Trials Services, Commercial Manufacturing, and Health and Nutrition Services. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its legal entity is NextPharma Technologies.
Company details
NextPharma is a pharmaceutical contract development and manufacturing organisation providing a full range of pharmaceutical services across the entire supply chain, including pharmaceutical development, formulation development, scale-up and process development, clinical trials services, analytical and microbiological services, commercial manufacturing and packaging, generic dossiers and licensing. It develops and produces a broad range of pharmaceutical dosage forms which include Solids (tablets, capsules, powders, controlled-release), Liquids (suspensions, syrups, solutions), and Semi-solids (creams, gels, ointments, suppositories). It has special containment areas for Hormones (solid and semi-solid), Narcotic and controlled substances, Penicillins, Cephalosporins (solids, liquids, dry syrups), and clinical trial services.
- Headquarters Gottingen, Germany
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website nextpharma.com
- Social LinkedIn
- Acquired by CapVest (Jun 2017)
- Legal Name Nextpharma Technologies
Products & Services of NextPharma
NextPharma offers a comprehensive portfolio of products and services, including Pharmaceutical Development, Clinical Trials Services, Commercial Manufacturing, and Health and Nutrition Services.
Supports drug projects from early stages to manufacturing processes.
Provides flexible supply services for clinical trial needs worldwide.
Handles manufacturing and packaging for commercial pharmaceutical products.
Offers trusted nutritional product development and manufacturing.
Investors in NextPharma
NextPharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include CapVest.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
CapVest is recognized as a leading private equity investor. | 1999 | capvest.com | London, United Kingdom |
Investor details for NextPharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NextPharma
47 people are tracked at NextPharma (22 in leadership, 25 in team).
| Name | Role | Group |
|---|---|---|
Farida Errabih | Head Of Finance And Administration | Leadership |
Andre Wohlgemuth | Head Of Quality Control | Leadership |
Joe Darling | Quality Director And Qualified Person | Leadership |
Dr. Daniela Pezzetta | Deputy Head Of Quality Assurance | Leadership |
John Marenghi | Business Development Director UK / Scandinavia | Leadership |
Andreas Henkel | Vice President Quality | Leadership |
Sebastian Barth | Global Head Of Serialization - IT Systems | Leadership |
Christophe Chrétien | Head Supply Chain Program Management | Leadership |
Pierre Delavaud | Executive Vice President Sales And Marketing | Leadership |
Peter Burema | CEO | Leadership |
Michael Dörr | Head Of Global Infrastructure And Security | Leadership |
Frank Heiner Eskuche | Business Development Director | Leadership |
Frédérique Turlin | Business Development Director | Leadership |
Christian Brache | Director Strategic Procurement | Leadership |
Eric Schmidhäuser | COO (chief Operating Officer) | Leadership |
Anke Luxenburger | Global Head Of Legal | Leadership |
Marcel Kruse | Head Of IT Manufacturing Systems | Leadership |
Maren Mielenhausen | Head Of Customer Service | Leadership |
Catherine Cornille | Business Development Director Early Phase Projects At Nextpharma | Leadership |
Alain Tourrel | Site Head | Leadership |
27 more people are available in the full profile.
Complete people profiles for NextPharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of NextPharma
2 dated milestones of NextPharma across 17 years, from founding to its latest funding, stage changes and deals.
- Founded NextPharma is founded.
- Exit Acquired by CapVest.
Web traffic of NextPharma
The website of NextPharma (nextpharma.com) receives about 8K visits a month and ranks #1,667,239 among all websites worldwide, #2,243 in Biotechnology and Pharmaceuticals.
- Monthly visits8K
▼ 47.6% vs previous month
- Unique visitors6.4K
per month
- Global rank#1,667,239
among all websites
- Category rank#2,243
Health · Biotechnology and Pharmaceuticals
- Bounce rate43%
- Pages per visit1.9
- Average visit53 sec
- DevicesDesktop 34% · Mobile 66%
Websites whose visitors overlap most with NextPharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| aesica-pharma.com | 100% | View details | |||
| lomapharm.de | 100% | 2K | #5,491,269 | View details | |
| fareva.com | 100% | 14.6K | #1,040,773 | View details | |
janssen-ortho.com | janssen-ortho.com | 94% | – | ||
| biofarmagroup.com | 85% | 15.7K | #1,639,133 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for NextPharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nextpharma
Complete news archive for NextPharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NextPharma
NextPharma was founded in 2000.
NextPharma is headquartered in Gottingen, Germany. It is registered at Gottingen, Niedersachsen, Germany.
Annual revenue of NextPharma is $126.57M as on Dec 31, 2015.
NextPharma is a pharmaceutical contract development and manufacturing organisation providing a full range of pharmaceutical services across the entire supply chain, including pharmaceutical development, formulation development, scale-up and process development, clinical trials services, analytical and microbiological services, commercial manufacturing and packaging, generic dossiers and licensing. It develops and produces a broad range of pharmaceutical dosage forms which include Solids (tablets, capsules, powders, controlled-release), Liquids (suspensions, syrups, solutions), and Semi-solids (creams, gels, ointments, suppositories). It has special containment areas for Hormones (solid and semi-solid), Narcotic and controlled substances, Penicillins, Cephalosporins (solids, liquids, dry syrups), and clinical trial services.
NextPharma offers Pharmaceutical Development, Clinical Trials Services, Commercial Manufacturing, and Health and Nutrition Services.
NextPharma has 1 investor. Key investors include CapVest.
NextPharma operates through Nextpharma Technologies.
Yes. NextPharma was acquired by CapVest in June 2017.